Journal of Nutrition LabDiet, Your World of Nutritional Answers

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


J. Nutr. First published January 21, 2009; doi:10.3945/jn.108.100115
Journal of Nutrition, doi:10.3945/jn.108.100115
Vol. 139, No. 3, 467-473, March 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
139/3/467    most recent
jn.108.100115v1
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaludjerovic, J.
Right arrow Articles by Ward, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaludjerovic, J.
Right arrow Articles by Ward, W. E.
© 2009 American Society for Nutrition


Nutrient Physiology, Metabolism, and Nutrient-Nutrient Interactions

Neonatal Exposure to Daidzein, Genistein, or the Combination Modulates Bone Development in Female CD-1 Mice1,2

Jovana Kaludjerovic and Wendy E. Ward*

Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Canada M5S 3E2

Neonatal exposure to genistein (GEN), an isoflavone abundant in soy, favorably modulates bone mineral density (BMD) and bone strength in mice at adulthood. The study objective was to determine whether early exposure to a combination of the soy isoflavones daidzein (DAI) and GEN that naturally exists in soy protein-based infant formula results in greater benefits to bone at adulthood than either treatment alone. Male and female CD-1 mice (n = 8–16 pups per group per gender) were randomized to subcutaneous injections of DAI (2 mg·kg body weight–1·d–1), GEN (5 mg·kg body weight–1·d–1), DAI+GEN (7 mg·kg body weight–1·d–1), diethylstilbesterol (DES; positive control) (2 mg·kg body weight–1·d–1), or control (CON) from postnatal d 1–5 and were studied to 4 mo of age. BMD, biomechanical bone strength, and bone microarchitecture were assessed at the femur and lumbar vertebrae (LV). Females treated with DAI, GEN, DAI+GEN, or DES had greater (P < 0.05) BMD at the LV compared with CON and vertebra in the DAI and DES group were more resistant to compression fractures. Microstructural analyses demonstrated that treatment with DAI and GEN resulted in greater (P < 0.05) trabecular connectivity and trabecular thickness, respectively, than the CON. In conclusion, neonatal exposure to DAI and/or GEN had a positive effect on the skeleton of female mice at adulthood, but, compared with individual treatments, DAI+GEN did not have a greater benefit to bone in females or males.


* To whom correspondence should be addressed. E-mail: wendy.ward{at}utoronto.ca.

Manuscript received 2 October 2008. Initial review completed 8 November 2008. Revision accepted 5 January 2009.

Published online 21 January 2009.




This article has been cited by other articles:


Home page
J. Nutr.Home page
J.-R. Chen, O. P. Lazarenko, M. L. Blackburn, J. V. Badeaux, T. M. Badger, and M. J. J. Ronis
Infant Formula Promotes Bone Growth in Neonatal Piglets by Enhancing Osteoblastogenesis through Bone Morphogenic Protein Signaling
J. Nutr., October 1, 2009; 139(10): 1839 - 1847.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2009 by American Society for Nutrition